SAMHSA releases final rule on opioid use disorder treatment
The Substance Abuse and Mental Health Services Administration Jan. 31 issued a final rule that updates certain regulations for Opioid Treatment Programs and the standards for treatment of opioid use disorder. The rule makes some COVID-19-related flexibilities permanent, including take-home doses of methadone, the ability of an OTP to prescribe medication for OUD via telehealth without an initial in-person physical evaluation, and the removal of certain requirements for admission to an OTP to better align with evidence-based practice.
Related News Articles
Headline
President Biden March 13 announced the White House Challenge to Save Lives from Overdose, a national call to action for the public and private sectors to…
Headline
Released during National Eating Disorder Awareness week, the latest AHA People Matter, Words Matter poster encourages compassionate and caring language when…
Headline
The Substance Abuse and Mental Health Services Administration Feb. 8 issued a final rule implementing Coronavirus Aid, Relief, and Economic Security Act…
Headline
The Substance Abuse and Mental Health Services Administration Jan. 31 updated its Overdose Prevention and Response Toolkit, which includes basic information on…
Headline
The House Dec. 12 voted 386-37 to pass AHA-supported legislation (H.R. 4531) that would reauthorize key SUPPORT Act programs for patients with substance use…
Headline
The AHA Dec. 7 sent a letter supporting the Support for Patients and Communities Reauthorization Act (H.R. 4531), bipartisan legislation that would reauthorize…